Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAJAJ HEALTHCARE 2022-23 Annual Report Analysis
Tue, 3 Oct

BAJAJ HEALTHCARE has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

BAJAJ HEALTHCARE Income Statement Analysis

  • Operating income during the year fell 1.0% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 9.9% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 15.9% in FY23 as against 17.5% in FY22.
  • Depreciation charges increased by 55.1% and finance costs increased by 79.9% YoY, respectively.
  • Other income grew by 10.7% YoY.
  • Net profit for the year declined by 39.7% YoY.
  • Net profit margins during the year declined from 10.5% in FY22 to 6.4% in FY23.

BAJAJ HEALTHCARE Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 6,799 6,733 -1.0%
Other income Rs m 14 16 10.7%
Total Revenues Rs m 6,813 6,749 -0.9%
Gross profit Rs m 1,187 1,070 -9.9%
Depreciation Rs m 176 274 55.1%
Interest Rs m 128 230 79.9%
Profit before tax Rs m 897 582 -35.1%
Tax Rs m 183 152 -17.0%
Profit after tax Rs m 714 430 -39.7%
Gross profit margin % 17.5 15.9
Effective tax rate % 20.4 26.1
Net profit margin % 10.5 6.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

BAJAJ HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY23 stood at Rs 4 billion as compared to Rs 3 billion in FY22, thereby witnessing an increase of 35.4%.
  • Long-term debt stood at Rs 937 million as compared to Rs 663 million during FY22, a growth of 41.2%.
  • Current assets rose 28% and stood at Rs 5 billion, while fixed assets rose 21% and stood at Rs 4 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 9 billion as against Rs 7 billion during FY22, thereby witnessing a growth of 25%.

BAJAJ HEALTHCARE Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 3,285 3,677 11.9
 
Current Liabilities Rs m 3,221 4,361 35.4
Long-term Debt Rs m 663 937 41.2
Total Liabilities Rs m 7,211 9,015 25.0
 
Current assets Rs m 3,983 5,097 28.0
Fixed Assets Rs m 3,228 3,917 21.4
Total Assets Rs m 7,211 9,015 25.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



BAJAJ HEALTHCARE Cash Flow Statement Analysis

  • BAJAJ HEALTHCARE's cash flow from operating activities (CFO) during FY23 stood at Rs -223 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs -934 million, an improvement of 24.9% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs 1 billion, an improvement of 113% on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs 157 million from the Rs -123 million net cash flows seen during FY22.

BAJAJ HEALTHCARE Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m 7 -223 -
Cash Flow from Investing Activities Rs m -748 -934 -
Cash Flow from Financing Activities Rs m 618 1,315 112.6%
Net Cash Flow Rs m -123 157 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for BAJAJ HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 15.6, an decline from the EPS of Rs 25.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 474.3, stands at 34.4 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.6 times, while the price to sales ratio stands at 1.9 times.
  • The company's price to cash flow (P/CF) ratio stood at 14.0 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 246.3 243.9
TTM Earnings per share Rs 25.9 15.6
Diluted earnings per share Rs 25.9 15.6
Price to Cash Flow x 10.6 14.0
TTM P/E ratio x 13.2 34.4
Price / Book Value ratio x 5.6 2.7
Market Cap Rs m 18,328 9,857
Dividends per share (Unadj.) Rs 1.5 1.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for BAJAJ HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.2x during FY23, from 1.2x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 3.5x during FY23, from 8.0x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 11.7% during FY23, from 21.7% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 17.6% during FY23, from 26.0% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 7.3% during FY23, from 11.7% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 1.2 1.2
Debtors’ Days Days 991 1,233
Interest coverage x 8.0 3.5
Debt to equity ratio x 0.2 0.3
Return on assets % 11.7 7.3
Return on equity % 21.7 11.7
Return on capital employed % 26.0 17.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how BAJAJ HEALTHCARE has performed over the last 5 years, please visit here.

BAJAJ HEALTHCARE Share Price Performance

Over the last one year, BAJAJ HEALTHCARE share price has moved up from Rs 348.0 to Rs 474.3, registering a gain of Rs 126.3 or around 36.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 28,484.6 (down 0.0%). Over the last one year it has moved up from 23,528.5 to 28,484.6, a gain of 4,956 points (up 21.1%).

Overall, the S&P BSE SENSEX is up 15.7% over the year.

(To know more, check out historical annual results for BAJAJ HEALTHCARE and quarterly results for BAJAJ HEALTHCARE)

Annual Report FAQs

What is the current share price of BAJAJ HEALTHCARE?

BAJAJ HEALTHCARE currently trades at Rs 327.0 per share. You can check out the latest share price performance of BAJAJ HEALTHCARE here...

What was the revenue of BAJAJ HEALTHCARE in FY23? How does it compare to earlier years?

The revenues of BAJAJ HEALTHCARE stood at Rs 6,749 m in FY23, which was down -0.9% compared to Rs 6,813 m reported in FY22.

BAJAJ HEALTHCARE's revenue has grown from Rs 2,808 m in FY19 to Rs 6,749 m in FY23.

Over the past 5 years, the revenue of BAJAJ HEALTHCARE has grown at a CAGR of 24.5%.

What was the net profit of BAJAJ HEALTHCARE in FY23? How does it compare to earlier years?

The net profit of BAJAJ HEALTHCARE stood at Rs 430 m in FY23, which was down -39.7% compared to Rs 714 m reported in FY22.

This compares to a net profit of Rs 831 m in FY21 and a net profit of Rs 252 m in FY20.

Over the past 5 years, BAJAJ HEALTHCARE net profit has grown at a CAGR of 27.4%.

What does the cash flow statement of BAJAJ HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of BAJAJ HEALTHCARE reveals:

  • Cash flow from operations decreased in FY23 and stood at Rs -223 m as compared to Rs 7 m in FY22.
  • Cash flow from investments decreased in FY23 and stood at Rs -934 m as compared to Rs -748 m in FY22.
  • Cash flow from financial activity increased in FY23 and stood at Rs 1,315 m as compared to Rs 618 m in FY22.

Here's the cash flow statement of BAJAJ HEALTHCARE for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations2522064367-223
From Investments-130-276-1,089-748-934
From Financial Activity-126337556181,315
Net Cashflow-4-37101-123157

What does the Key Ratio analysis of BAJAJ HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of BAJAJ HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and stood at 15.9% in FY23 as against 17.5% in FY22.
  • Net profit margins declined from 10.5% in FY22 to 6.4% in FY23.
  • Debt to Equity ratio for FY23 stood at 0.3 as compared to 0.2 in FY22.

Here's the ratio/financial analysis of BAJAJ HEALTHCARE for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)15.311.820.817.515.9
Net Profit Margin (%)5.86.212.710.56.4
Debt to Equity Ratio (x)0.10.10.30.20.3

 

Equitymaster requests your view! Post a comment on "BAJAJ HEALTHCARE 2022-23 Annual Report Analysis". Click here!